Table 1.
Demographic Data and Clinical Characteristics of 87 Patients with IBD
| Characteristics | UC (n=45) | CD (n=42) | All patients (n=87) |
|---|---|---|---|
| Age (yr) | 48.5±13.7 | 40.9±15.6 | 44.9±15.1 |
| Male sex | 28 (62.2) | 29 (69.0) | 57 (65.5) |
| BMI (kg/m2) | 22.6±3.4 | 21.5±4.5 | 22.1±4.0 |
| Smoker | 7 (15.6) | 7 (16.7) | 14 (16.1) |
| Disease duration (yr) | 6.4±5.7 | 2.9±2.4 | 4.7±4.8 |
| Disease location for UC | - | - | |
| Proctitis | 15 (33.3) | ||
| Left-sided colitis | 9 (20.0) | ||
| Extensive colitis | 21 (46.7) | ||
| Disease location for CD | - | - | |
| Ileal | 11 (26.2) | ||
| Colonic | 8 (19.0) | ||
| Ileocolonic | 23 (54.8) | ||
| Medication | |||
| 5-ASA | 45 (100) | 41 (97.6) | 86 (98.9) |
| Prednisolone | 25 (55.6) | 24 (57.1) | 49 (56.3) |
| Immunomodulators (AZA/MTX/6-MP) | 23 (51.1) | 26 (61.9) | 49 (56.3) |
| Anti-TNF (infliximab/adalimumab) | 11 (24.4) | 17 (40.5) | 28 (32.2) |
| IBD-related surgery | 2 (4.4) | 3 (7.1) | 5 (5.7) |
| Mean 25-OH vitamin D (ng/mL) | 17.1±9.7 | 15.4±8.2 | 16.3±9.0 |
| Vitamin D deficiency (<20 ng/mL) | 33 (73.3) | 31 (73.8) | 64 (73.6) |
| Hemoglobin (g/dL) | 13.5±2.3 | 13.9±1.5 | 13.7±1.9 |
| WBC (×106 cells/μL) | 7.4±2.8 | 6.7±2.8 | 7.0±2.8 |
| ESR (mm/hr) | 21.6±23.9 | 27.7±23.8 | 24.6±23.9 |
| CRP (mg/dL) | 0.9±2.5 | 0.4±0.5 | 0.7±1.9 |
| Albumin (g/dL) | 4.3±0.4 | 4.3±0.6 | 4.3±0.5 |
| Total cholesterol (mg/dL) | 181.3±35.0 | 173.6±43.0 | 177.6±39.0 |
Values are presented as mean±SD or number (%).
5-ASA, 5-aminosalicylic acid; AZA, azathioprine; MTX, methotrexate; 6-MP, 6-mercaptopurine; 25-OH vitamin D, 25-hydroxyvitamin D; WBC, white blood cells.